FDA places partial clinical hold on BioCryst’s lead candidate, BCX9930

May 9, 2022
Sales and Marketing

The FDA has imposed a partial clinical hold on BioCryst’s Factor D inhibitor, BCX9930. The clinical hold arrives around a …

Case of monkeypox confirmed in England

May 9, 2022
Sales and Marketing

The UK Health Security Agency has confirmed that a person in England has been diagnosed with the monkeypox virus.The patient …

san

Shabir Hasham

May 6, 2022

Shabir Hasham has served as Santhera’s Global Development Program Lead & Global Head Medical Affairs for the past three years, …

san

Shabir Hasham

May 6, 2022

Shabir Hasham has served as Santhera’s Global Development Program Lead & Global Head Medical Affairs for the past three years, …

Allison Williamson

May 6, 2022

BIOCAPTIVA has announced the appointment of Alison Williamson as Chief Financial Officer, and member of the board.Alison has over 30 …

richard_laxer

Richard Laxer

May 6, 2022

Richard Laxer joins Oxford Science Enterprises as an independent non-executive director. Richard is a veteran of GE Capital, serving the …

karen_mullen_boyds

Dr Karen Mullen

May 6, 2022

Dr Karen Mullen joins Boyds from GlaxoSmithKline, where, as Country Medical Director for UK and Ireland, she led and managed …

karen_mullen_boyds

Dr Karen Mullen

May 6, 2022

 

Appy Days: How the smartphone app is revolutionising mental healthcare

May 6, 2022

Over the last decade, our individual awareness and understanding of mental health has risen to unprecedented levels. Despite its pitfalls, …

WHO launches first ever global report on Infection Prevention and Control

May 6, 2022
Medical Communications

A new report from WHO has highlighted the importance of effective IPC programmes, and shown that where good hand hygiene …

Open Orphan to begin first-ever COVID-19 challenge trial

May 6, 2022
Medical Communications

Open Orphan has been appointed by an unnamed existing “big pharma” client to host a Phase II field study of …

FDA narrows use of J&J vaccine due to blood clot risk

May 6, 2022
Medical Communications

The FDA has limited the use of Johnson & Johnson’s coronavirus vaccine, to adults who cannot, or refuse to get, …

AstraZeneca’s heart disease drug meets key endpoints in Phase III

May 6, 2022
Medical Communications

AstraZeneca’s treatment for heart disease has delivered positive high-level results from its Phase III DELIVER trial.Farxiga (dapagliflozin) is already approved …

First regenerative cell therapy for hearing loss

May 5, 2022
Business Services

Rinri Therapeutics have announced the MHRA has awarded an innovation passport to the company’s lead candidate, Rincell-1. Rincell-1 is a …

Nearly three million people receive lifesaving NHS cancer checks

May 5, 2022
Business Services

A record three million people received vital NHS cancer tests from March 2021 to February 2022, compared to 2.4 million …

Health experts report more symptoms of long COVID-19

May 5, 2022
Business Services

According to health experts, many COVID-19 patients are still suffering the effects of the condition months after they first started …

FDA approval for first in vitro diagnostic for early Alzheimer’s detection

May 5, 2022
Business Services

The US FDA has approved the first in vitro diagnostic to aid in the early detection of Alzheimer’s disease (AD). …

BLINCYTO approved in China for leukaemia treatment

May 4, 2022
Research and Development

The China National Medical Products Administration (NMPA) has granted conditional approval of BLINCYTO (blinatumomab), as an injection for the treatment …

Amphista Therapeutics and Bristol Myers Squibb partner for development of protein degradation therapeutics

May 4, 2022
Research and Development

Amphista and Bristol-Myers Squibb have announced a strategic collaboration and license agreement.Under the terms of the collaboration, BMS and Amphista …

Smartphone app could screen for Alzheimer’s disease

May 4, 2022
Research and Development

Researchers at the University of California San Diego have developed a smartphone app with the potential to screen for Alzheimer’s …

The Gateway to Local Adoption Series

Latest content